Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Utilization of Chromosomal Microarray Technologies for Hematologic Neoplasms: An ACLPS Critical Review.

American journal of clinical pathology - 1 Oct 2018

Peterson Jess F, Van Dyke Daniel L, Hoppman Nicole L, Kearney Hutton M, Sukov William R, Greipp Patricia T, Ketterling Rhett P, Baughn Linda B

Abstract excerpt

OBJECTIVES: Chromosome (G-banding) and fluorescence in situ hybridization (FISH) serve as the primary methodologies utilized for detecting genetic aberrations in hematologic neoplasms. Chromosomal microarray can detect copy number aberrations (CNAs) with greater resolution when compared to G-banding and FISH, and can also identify copy-neutral loss of heterozygosity (CN-LOH). The purpose of our review is to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Burkitt Lymphoma
Share to Chromosome Banding

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Comparative Genomic Hybridization

Share to Hematologic Neoplasms

Share to In Situ Hybridization, Fluorescence

Share to Karyotype

Share to Leukemia, B-Cell

Share to Loss of Heterozygosity

Source

Identifiers

PMID: 30052716
DOI: 10.1093/ajcp/aqy076

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Utilization of Chromosomal Microarray Technologies for Hematologic Neoplasms: An ACLPS Critical Review.PMID 30052716Read ↗

Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies.Semantic proximity Read ↗

Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?Semantic proximity Read ↗

American College of Medical Genetics and Genomics technical standards and guidelines: microarray analysis for chromosome abnormalities in neoplastic disordersSemantic proximity Read ↗

Array Comparative Genomic Hybridization Detects Chromosomal Abnormalities in Hematological Cancers That Are Not Detected by Conventional CytogeneticsSemantic proximity Read ↗

Detection of Chromosomal Aberrations in Clinical Practice: From Karyotype to Genome SequenceSemantic proximity Read ↗

Clinical application of microarray-based molecular cytogenetics: an emerging new era of genomic medicine.Semantic proximity Read ↗

Guidelines for genomic array analysis in acquired haematological neoplastic disordersSemantic proximity Read ↗

Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies.Semantic proximity Read ↗

Clinical laboratory implementation of cytogenomic microarrays.Semantic proximity Read ↗

Chromosomal Microarray Analysis in the Era of Optical Genome Mapping: Clinical Implications in Detecting Copy-Neutral EventsSemantic proximity Read ↗

Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer genomics consortium (CGC) working group for myelodysplastic syndrome, myelodysplastic/myeloproliferative and myeloproliferative neoplasmsSemantic proximity Read ↗

The use of cytogenetic microarrays in myelodysplastic syndrome characterization.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.